- US11655457utility2023Methods of Enhancing the Sialic Acid Content of a Cho-expressed Recombinant Glycoprotein0 cites
- US11649212utility2023Inhibitors of Indoleamine 2,3-dioxygenase and Methods of Their Use0 cites
- US11639353utility2023Cyclobutanes- and Azetidine-containing Mono and Spirocyclic Compounds as Αv Integrin Inhibitors0 cites
- US11623965utility2023Prodruggable Antibodies, Prodrugs Thereof, and Methods of Use and Making0 cites
- US11623921utility2023Indole Carboxamide Compounds0 cites
- US11618753utility2023Aminopyrrolotriazines as Kinase Inhibitors0 cites
- US11612654utility2023Combination Therapy Comprising Nivolumab and Ipilimumab0 cites
- US11613585utility2023Nucleic Acids Encoding Antagonistic CD40 Monoclonal Antibodies0 cites
- US11603410utility2023Immunostimulatory Agonistic Antibodies for Use in Treating Cancer0 cites
- US11603406utility2023Antibodies Binding to VISTA at Acidic Ph0 cites
- US11597721utility2023Heterocyclic Compounds Comprising Pyridine Useful as Modulators of IL-12, IL-23 And/or Ifnα Responses0 cites
- US11591314utility2023Process for Preparing Tetrahydrocarbazole Carboxamide Compound0 cites
- US11591392utility2023Antibodies Against TIM3 and Uses Thereof0 cites
- US11578054utility2023Compounds Useful as Immunomodulators0 cites
- US11576841utility2023Handheld Medicament Dispenser0 cites
- US11572405utility2023Combination Therapy with Anti-il-8 Antibodies and Anti-pd-1 Antibodies for Treating Cancer0 cites
- US11566073utility2023Methods of Treating a Tumor Using an Anti-pd-1 Antibody0 cites